Filing Details
- Accession Number:
- 0001437749-11-009753
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-12-22 16:49:47
- Reporting Period:
- 2011-12-21
- Filing Date:
- 2011-12-22
- Accepted Time:
- 2011-12-22 16:49:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 352747 | Unigene Laboratories Inc | UGNE | Medicinal Chemicals & Botanical Products (2833) | 222328609 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1502054 | Roxanne Tavakkol | C/O Unigene Laboratories, Inc 81 Fulton Street Boonton NJ 07005 | Vp, Global Regulatory Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-12-21 | 1,500 | $0.64 | 1,500 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
